News Formal

Pfizer cuts earnings outlook on lower Covid-19 drug sales

  • 📰 manilabulletin
  • ⏱ Reading Time:
  • 30 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 15%
  • Publisher: 51%

日本 ニュース ニュース

日本 最新ニュース,日本 見出し

NEW YORK, United States–The US pharmaceutical giant Pfizer sharply scaled back its earnings outlook for the year, blaming lower-than-expected sales of two drugs used to treat Covid-19, the company said Friday.

NEW YORK, United States–The US pharmaceutical giant Pfizer sharply scaled back its earnings outlook for the year, blaming lower-than-expected sales of two drugs used to treat Covid-19, the company said Friday.

Earnings per share - the benchmark for the markets - should come in at between 1.45 and 1.65 dollars, compared with 3.25 to 3.45 dollars previously anticipated."Full-year 2023 revenues for Paxlovid and Comirnaty are expected to be approximately $12.5 billion, a decline of $9.0 billion versus original expectations," it added.

The company's shares were more than three percent lower in after hours trading at 5:30pm local time in New York .Test positivity rates, hospitalizations and deaths due to the virus are all down over the last week, according to CDC data.

 

コメントありがとうございます。コメントは審査後に公開されます。
このニュースをすぐに読めるように要約しました。ニュースに興味がある場合は、ここで全文を読むことができます。 続きを読む:

 /  🏆 25. in JP

日本 最新ニュース, 日本 見出し

Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。

Pfizer cuts earnings outlook on lower Covid-19 drug salesNEW YORK, United States - The US pharmaceutical giant Pfizer sharply scaled back its earnings outlook for the year, blaming lower-than-expected sales of two drugs used to treat Covid-19, the company said Friday.
ソース: manilabulletin - 🏆 25. / 51 続きを読む »

Pfizer cuts earnings outlook on lower Covid-19 drug salesDefining the News
ソース: MlaStandard - 🏆 20. / 55 続きを読む »